InfuSystem Holdings, Inc. (NYSE:INFU) Sees Significant Increase in Short Interest

InfuSystem Holdings, Inc. (NYSE:INFU) was the recipient of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 508,000 shares, a growth of 27.1% from the May 15th total of 399,700 shares. Based on an average daily volume of 149,400 shares, the short-interest ratio is currently 3.4 days. Approximately 2.7% of the company’s shares are short sold.

Institutional Trading of InfuSystem

A number of institutional investors have recently added to or reduced their stakes in INFU. Nuveen Asset Management LLC lifted its stake in shares of InfuSystem by 14.1% in the 4th quarter. Nuveen Asset Management LLC now owns 86,379 shares of the company’s stock valued at $730,000 after purchasing an additional 10,647 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in InfuSystem by 67.9% during the fourth quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company’s stock valued at $58,000 after purchasing an additional 2,768 shares during the last quarter. Deutsche Bank AG lifted its stake in shares of InfuSystem by 148.3% in the fourth quarter. Deutsche Bank AG now owns 27,671 shares of the company’s stock worth $234,000 after buying an additional 16,526 shares during the last quarter. Two Sigma Investments LP boosted its holdings in shares of InfuSystem by 40.4% during the 4th quarter. Two Sigma Investments LP now owns 36,252 shares of the company’s stock worth $306,000 after buying an additional 10,427 shares during the period. Finally, Northern Trust Corp raised its holdings in InfuSystem by 7.7% in the 4th quarter. Northern Trust Corp now owns 186,741 shares of the company’s stock worth $1,578,000 after acquiring an additional 13,333 shares during the period. 71.13% of the stock is currently owned by institutional investors and hedge funds.

InfuSystem Stock Up 0.5%

INFU opened at $6.19 on Friday. The company has a market capitalization of $130.09 million, a PE ratio of 103.18 and a beta of 1.81. The business has a 50-day moving average of $5.49 and a 200-day moving average of $6.74. InfuSystem has a fifty-two week low of $4.61 and a fifty-two week high of $9.97. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59.

Wall Street Analyst Weigh In

INFU has been the subject of a number of research analyst reports. Sidoti upgraded InfuSystem to a “strong-buy” rating in a report on Tuesday, March 18th. B. Riley raised shares of InfuSystem to a “strong-buy” rating in a research report on Thursday, May 8th. Finally, Wall Street Zen downgraded shares of InfuSystem from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, May 14th.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.